Cornerstone Investment Partners, LLC Compugen LTD Transaction History

Cornerstone Investment Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 25, 2021	SELL	$5.8 - $8.02 $112,868 - $156,069	-19,460 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$7.67 - $13.77 $4,985 - $8,950	650 Added 3.46%	19,460 $167,000
Q4 2020 Jan 28, 2021	SELL	$12.07 - $17.95 $1,207 - $1,795	-100 Reduced 0.53%	18,810 $228,000
Q3 2020 Oct 30, 2020	BUY	$14.16 - $19.45 $2,832 - $3,890	200 Added 1.07%	18,910 $307,000
Q2 2020 Jul 30, 2020	BUY	$6.97 - $17.12 $2,439 - $5,992	350 Added 1.91%	18,710 $281,000
Q1 2020 Apr 27, 2020	BUY	$5.79 - $11.83 $4,979 - $10,173	860 Added 4.91%	18,360 $133,000
Q4 2018 Jan 11, 2019	BUY	$2.17 - $3.8 $37,975 - $66,500	17,500 New	17,500 $38,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $129M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Cornerstone Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cornerstone Investment Partners, LLC with notifications on news.